IDH1 and glioblastoma: Therefore, in order to investigate the prognostic significance and prospective therapeutic options of nrlncRNAs in IDH-wild-type GBM and to elucidate the role of nrlncRNAs in the TME, the following research was conducted: we developed a predictive risk model based on nrlncRNA to predict the prognosis of IDH-wild-type GBM patients and serve as a guide for clinical diagnosis and treatment.